Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 109

1.

Outcome of mantle cell lymphoma patients treated at a single institution over the past decade.

Hitz F, Diem S, Haile SR, Ess S, Cerny T, Mey U.

Hematol Oncol. 2014 Dec;32(4):192-6. doi: 10.1002/hon.2123. Epub 2013 Dec 11.

PMID:
24338732
2.

Confirmation of the mantle-cell lymphoma International Prognostic Index in randomized trials of the European Mantle-Cell Lymphoma Network.

Hoster E, Klapper W, Hermine O, Kluin-Nelemans HC, Walewski J, van Hoof A, Trneny M, Geisler CH, Di Raimondo F, Szymczyk M, Stilgenbauer S, Thieblemont C, Hallek M, Forstpointner R, Pott C, Ribrag V, Doorduijn J, Hiddemann W, Dreyling MH, Unterhalt M.

J Clin Oncol. 2014 May 1;32(13):1338-46. doi: 10.1200/JCO.2013.52.2466. Epub 2014 Mar 31.

PMID:
24687837
3.

Prognostic impact of monocyte count at presentation in mantle cell lymphoma.

von Hohenstaufen KA, Conconi A, de Campos CP, Franceschetti S, Bertoni F, Margiotta Casaluci G, Stathis A, Ghielmini M, Stussi G, Cavalli F, Gaidano G, Zucca E.

Br J Haematol. 2013 Aug;162(4):465-73. doi: 10.1111/bjh.12409. Epub 2013 Jun 29.

PMID:
23808798
4.

Mantle cell lymphoma: 2012 update on diagnosis, risk-stratification, and clinical management.

Vose JM.

Am J Hematol. 2012 Jun;87(6):604-9. doi: 10.1002/ajh.23176. Review.

5.

Mantle irradiation alone for pathologic stage I and II Hodgkin's disease: long-term follow-up and patterns of failure.

Liao Z, Ha CS, Vlachaki MT, Hagemeister F, Cabanillas F, Hess M, Tucker S, Cox JD.

Int J Radiat Oncol Biol Phys. 2001 Jul 15;50(4):971-7.

PMID:
11429225
6.

Mantle cell lymphoma in the ocular adnexal region.

Looi A, Gascoyne RD, Chhanabhai M, Connors JM, Rootman J, White VA.

Ophthalmology. 2005 Jan;112(1):114-9.

PMID:
15629830
7.

A phase II clinical trial of intensive chemotherapy followed by consolidative stem cell transplant: long-term follow-up in newly diagnosed mantle cell lymphoma.

Evens AM, Winter JN, Hou N, Nelson BP, Rademaker A, Patton D, Singhal S, Frankfurt O, Tallman MS, Rosen ST, Mehta J, Gordon LI.

Br J Haematol. 2008 Feb;140(4):385-93. Epub 2007 Dec 19.

PMID:
18162124
8.

Molecular remission is an independent predictor of clinical outcome in patients with mantle cell lymphoma after combined immunochemotherapy: a European MCL intergroup study.

Pott C, Hoster E, Delfau-Larue MH, Beldjord K, Böttcher S, Asnafi V, Plonquet A, Siebert R, Callet-Bauchu E, Andersen N, van Dongen JJ, Klapper W, Berger F, Ribrag V, van Hoof AL, Trneny M, Walewski J, Dreger P, Unterhalt M, Hiddemann W, Kneba M, Kluin-Nelemans HC, Hermine O, Macintyre E, Dreyling M.

Blood. 2010 Apr 22;115(16):3215-23. doi: 10.1182/blood-2009-06-230250. Epub 2009 Dec 23.

9.

Blastic variant of mantle cell lymphoma: a rare but highly aggressive subtype.

Bernard M, Gressin R, Lefrère F, Drénou B, Branger B, Caulet-Maugendre S, Tass P, Brousse N, Valensi F, Milpied N, Voilat L, Sadoun A, Ghandour C, Hunault M, Leloup R, Mannone L, Hermine O, Lamy T.

Leukemia. 2001 Nov;15(11):1785-91.

PMID:
11681422
10.

The clinical features, therapeutic responses, and prognosis of the patients with mantle cell lymphoma.

Ying ZT, Zheng W, Wang XP, Xie Y, Tu MF, Lin NJ, Ping LY, Liu WP, Deng LJ, Zhang C, Zhu J, Song YQ.

Chin J Cancer. 2012 Jul;31(7):348-53. doi: 10.5732/cjc.011.10469. Epub 2012 Jun 14.

11.

Treatment strategies in mantle cell lymphoma.

Maddocks K, Blum KA.

Cancer Treat Res. 2015;165:251-70. doi: 10.1007/978-3-319-13150-4_10. Review.

PMID:
25655613
12.

Mantle cell lymphoma: 2013 Update on diagnosis, risk-stratification, and clinical management.

Vose JM.

Am J Hematol. 2013 Dec;88(12):1082-8. doi: 10.1002/ajh.23615. Review.

13.

Absolute monocyte count predicts overall survival in mantle cell lymphomas: correlation with tumour-associated macrophages.

Koh YW, Shin SJ, Park C, Yoon DH, Suh C, Huh J.

Hematol Oncol. 2014 Dec;32(4):178-86. doi: 10.1002/hon.2106. Epub 2013 Oct 29.

PMID:
24910369
14.

[Clinical Characteristics and Prognosis of 34 Patients with Mantle Cell Lymphoma: A Retrospective Analysis].

Chen XP, Zhao Y, Wang QS, Lv N, Li YH, Jing Y, Yu L.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2015 Dec;23(6):1601-6. doi: 10.7534/j.issn.1009-2137.2015.06.014. Chinese.

PMID:
26708879
15.

Bendamustine as salvage treatment for patients with relapsed or refractory mantle cell lymphoma patients: a retrospective study of the Spanish experience.

García-Noblejas A, Martínez Chamorro C, Navarro Matilla B, Da Silva Rodriguez C, González-Lopez TJ, Oña Navarrete R, Ramírez Sánchez MJ, Martínez Barranco P, Sánchez Blanco JJ, Nicolás C, Pérez R, Sánchez González B, Ruedas López AM, Domingo-Domenech E, Panizo C, Macia S, Fernández-Fonseca E, Cannata-Ortiz J, Arranz R.

Ann Hematol. 2014 Sep;93(9):1551-8. doi: 10.1007/s00277-014-2077-1. Epub 2014 Apr 30.

PMID:
24782117
16.

Mantle cell lymphoma: clinical features, treatment and prognosis of 94 patients.

Oinonen R, Franssila K, Teerenhovi L, Lappalainen K, Elonen E.

Eur J Cancer. 1998 Feb;34(3):329-36.

PMID:
9640217
17.

Diagnosis and treatment of mantle cell lymphoma.

Hitz F, Bargetzi M, Cogliatti S, Lohri A, Taverna C, Renner C, Mey U.

Swiss Med Wkly. 2013 Nov 13;143:w13868. doi: 10.4414/smw.2013.13868. Review.

18.

Phase I/II study of bortezomib-BEAM and autologous hematopoietic stem cell transplantation for relapsed indolent non-Hodgkin lymphoma, transformed, or mantle cell lymphoma.

William BM, Allen MS, Loberiza FR Jr, Bociek RG, Bierman PJ, Armitage JO, Vose JM.

Biol Blood Marrow Transplant. 2014 Apr;20(4):536-42. doi: 10.1016/j.bbmt.2014.01.004. Epub 2014 Jan 14.

19.

Real world data on primary treatment for mantle cell lymphoma: a Nordic Lymphoma Group observational study.

Abrahamsson A, Albertsson-Lindblad A, Brown PN, Baumgartner-Wennerholm S, Pedersen LM, D'Amore F, Nilsson-Ehle H, Jensen P, Pedersen M, Geisler CH, Jerkeman M.

Blood. 2014 Aug 21;124(8):1288-95. doi: 10.1182/blood-2014-03-559930. Epub 2014 May 23.

20.

Cladribine plus rituximab is an effective therapy for newly diagnosed mantle cell lymphoma.

Spurgeon SE, Pindyck T, Okada C, Chen Y, Chen Z, Mater E, Abbi K, Epner EM.

Leuk Lymphoma. 2011 Aug;52(8):1488-94. doi: 10.3109/10428194.2011.575489. Epub 2011 May 31.

PMID:
21623691

Supplemental Content

Support Center